COVID-19 vaccine: great news for Arania
The arrival of an effective vaccine against COVID-19 has brought some optimism for the future. The recovery of the sectors and services most affected by the crisis will ultimately benefit the normalisation of industrial activity: we will be able to travel again, reinforcing commercial relations and deploying the excellence of the Arania brand worldwide.
Since the announcement of an effective vaccine against COVID-19 by the American pharmaceutical company Pfizer and the election of Joe Biden as future US president, the economic situation seems to be turning less pessimistic, with hope of recovering relative levels of stability. If the best predictions are finally fulfilled and a vaccine with over 90% effectiveness is obtained, 2021 will be the starting point for a stabilisation process in developed countries both in sanitary and economic terms, which will continue with the normalisation of movements of people and exchanges between countries.
As a leading company in cold-rolled steel and high yield strength steel, Arania is observing how, for the first time since the panic started in February and March, markets are beginning to think seriously about a global economy that could operate normally. Now, the key is how to adopt a proactive stance towards this so well-received return to normality.
The activities most affected by the pandemic, usually within the service sector, are precisely the most exposed to social mobility restrictions. Despite the severe blow to virtually all sectors, industry or agriculture, for example, have been less affected by these limitations. However, the months-long standstill in international congresses, trade fairs and business meetings is a shock to all activities, including cold-rolled steel and high yield strength steel industry.
In this sense, a general recovery of the economic wheel is great news for Arania. The sooner we will be able to travel again, reinforcing commercial relations, expanding our presence in new markets… the sooner we will provide the best solutions in cold rolled steel to our clients and their collaborators all over the world.
However, there are still many doubts regarding this COVID-19 vaccine, including its impact and possible repercussions on the economy in the event of a failed attempt. Indeed, a large part of the population is wary about new drugs, and many people will directly refuse any vaccine against COVID-19.
In this scenario, in addition to the effectiveness of the vaccine, the key to future economic reactivation will depend on the pace of relaxation of current restrictions. This progress will logically rely on the effectiveness and availability of the vaccine, on productive specialisation and on the economic and health conditions existing in each territory, whether at local or European level. Recovery will obviously be hampered by the structural damage caused by the economic pandemic to the local productive network.
As a leading industrial group in the steel sector specially focused on exports, the Arania Group faces the future from a consolidated position, marked by the trust of major customers and first line international companies. Thanks to the protection measures introduced and the reorientation of industrial priorities promoted within the Marco 3R strategy (Resist, Rebuild, Renew), the cold-rolled precision steel solutions offered by Arania will continue to set the standards in terms of deadlines, quality, flexibility and maximum availability for all its collaborators.
However, the news around Pfizer’s new COVID-19 vaccine must be taken with caution, but we cannot ignore that, sooner rather than later, Arania’s teams will once again travel the world to strengthen business relationships, seek new opportunities and deploy the excellence of the Arania brand before the eyes of clients, collaborators and competitors.